\(
\def\WIPO{World Intellectual Property Organisation}
\)
The Role of Intellectual Property Rights in Biotechnology Innovation
Castle, David. Editor.; B. Asheim, C. Ayerbe, R.Y. Boadi, J.A. Bovenberg, T. Bubela, D. Castle, T. Caulfield, S. Chaturvedi, L.M. Cloutier, L.M. Cloutier, A.S. Daar, K.L. Durell, C.W. Francis, A.J. Glass, E.R. Gold, J.A. Holbrook, M. Ingham, I. Inkster, A.G. Isaac, F.S. Kieff, C. May, E. Métais, L. Mitkova, F.X. Nunez, S. Oriel, W.G. Park, T. Piper, S. Sirois, P.H. Sullivan, K. Sumikura, F. Valentin, C. Zeller. Contributors.
2009
F 630 CAS.R
Available at WIPO Library
格式
| 格式 | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
详细记录
Title
The Role of Intellectual Property Rights in Biotechnology Innovation
Author
Castle, David. Editor.
B. Asheim, C. Ayerbe, R.Y. Boadi, J.A. Bovenberg, T. Bubela, D. Castle, T. Caulfield, S. Chaturvedi, L.M. Cloutier, L.M. Cloutier, A.S. Daar, K.L. Durell, C.W. Francis, A.J. Glass, E.R. Gold, J.A. Holbrook, M. Ingham, I. Inkster, A.G. Isaac, F.S. Kieff, C. May, E. Métais, L. Mitkova, F.X. Nunez, S. Oriel, W.G. Park, T. Piper, S. Sirois, P.H. Sullivan, K. Sumikura, F. Valentin, C. Zeller. Contributors.
B. Asheim, C. Ayerbe, R.Y. Boadi, J.A. Bovenberg, T. Bubela, D. Castle, T. Caulfield, S. Chaturvedi, L.M. Cloutier, L.M. Cloutier, A.S. Daar, K.L. Durell, C.W. Francis, A.J. Glass, E.R. Gold, J.A. Holbrook, M. Ingham, I. Inkster, A.G. Isaac, F.S. Kieff, C. May, E. Métais, L. Mitkova, F.X. Nunez, S. Oriel, W.G. Park, T. Piper, S. Sirois, P.H. Sullivan, K. Sumikura, F. Valentin, C. Zeller. Contributors.
描述
480 pages ; 23 cm
国际图书编号
9781848447882 Print
9781849801935 eBook
9781849801935 eBook
Alternate Call Number
F 630 CAS.R
摘要
Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation. An international group of scholars from a range of disciplines – economic geography, health law, business, philosophy, history, public health, management – examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems. Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.
书目等附注
Includes bibliographical references and index.
格式化内容附注
Introduction
Part I: Intellectual Property Rights in Innovation Systems – Introduction; 1. Are Intellectual Property Rights Quanta of Innovation?; 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context; 3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership
Part II: Intellectual Property Management In Biotechnology – Introduction; 4. Fundamentals of Intellectual Property Management; 5. Making a Return on R&D: A Business Perspective; 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology
Part III: Intellectual Property Rights in Relation to Other Measures of Innovation – Introduction; 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements; 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation; 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes
Part IV: Beyond Patent Length – Introduction; 10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?; 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits; 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology
Part V: Innovation Governance – Introduction; 13. Accessibility of Biological Data: A Role for the European Database Right?; 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?; 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries
Part VI: National, International and Historical Comparisons – Introduction; 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons; 17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000; 18. Watch What You Export: The History of Medical Exceptions from Patentability
Index
Part I: Intellectual Property Rights in Innovation Systems – Introduction; 1. Are Intellectual Property Rights Quanta of Innovation?; 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context; 3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership
Part II: Intellectual Property Management In Biotechnology – Introduction; 4. Fundamentals of Intellectual Property Management; 5. Making a Return on R&D: A Business Perspective; 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology
Part III: Intellectual Property Rights in Relation to Other Measures of Innovation – Introduction; 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements; 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation; 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes
Part IV: Beyond Patent Length – Introduction; 10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?; 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits; 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology
Part V: Innovation Governance – Introduction; 13. Accessibility of Biological Data: A Role for the European Database Right?; 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?; 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries
Part VI: National, International and Historical Comparisons – Introduction; 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons; 17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000; 18. Watch What You Export: The History of Medical Exceptions from Patentability
Index
连续资源
Published
Cheltenham : Edward Elgar, 2009.
语言
eng